A pause on furniture tariffs sparked an RH rally, but stretched multiples suggest optimism may be running ahead of ...

MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development stage company focused on pioneering an intelligent automated diuretic and fluid management approach for acute ...

China Vanke Co.’s woes are posing a growing risk for investors holding $1.3 billion of the embattled developer’s dollar bonds, as a temporary reprieve this week on local debt still leaves it lurching ...

S&P Global Ratings downgraded China Vanke Co. to selective default on Tuesday, labeling the developer’s recent onshore bond extension as a distressed debt restructuring tantamount to a default.

Reprieve Cardiovascular today announced results for its first-in-human study of the Reprieve system for the treatment of acute decompensated heart failure (ADHF). The study focused on the device’s ...

-- Late-Breaking Clinical Data Presented at the Technology and Heart Failure Therapeutics (THT) Annual Meeting Demonstrates Safety and Efficacy of the Reprieve System Compared to Optimal Diuretic ...

A daily statin can reduce the risk of new-onset cardiovascular disease in people living with HIV, according to preliminary results from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE ...

ATHENS, Greece—A device-based fluid-management system that regulates decongestion in conjunction with diuretic therapy appears safe and is able to successfully control fluid loss in patients ...

Oasis, the LGBTQ nightclub in San Francisco's South of Market district, has been saved from permanently closing by "a ...

The author wrote a novel about a murder in a haunted house, but that's the least scary thing about it. It would be easy to read James Han Mattson's new novel and assume he is a master of the macabre.

When you purchase an independently reviewed book through our site, we earn an affiliate commission. By Victor LaValle REPRIEVE By James Han Mattson Why do people enjoy being scared? This is a pretty ...

MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) treatment, today announced topline results ...